[
    [
        {
            "time": "",
            "orginal_text": "3个⽉仓位猛打⾄90%！知名基⾦经理调仓动向曝光",
            "features": {
                "keywords": [
                    "仓位",
                    "90%",
                    "基金经理",
                    "调仓"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "基金"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "3个⽉仓位猛打⾄90%！知名基⾦经理调仓动向曝光",
            "scores": {
                "News_content": "3个⽉仓位猛打⾄90%！知名基⾦经理调仓动向曝光",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "【今日机构评级汇总】小摩认为Roku能抓住更多“重⼤”广告机会；杰富瑞看好理想汽车对动⼒系统的选择",
            "features": {
                "keywords": [
                    "Roku",
                    "广告机会",
                    "理想汽车",
                    "动力系统"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "科技",
                    "汽车"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "【今日机构评级汇总】小摩认为Roku能抓住更多“重⼤”广告机会；杰富瑞看好理想汽车对动⼒系统的选择",
            "scores": {
                "News_content": "【今日机构评级汇总】小摩认为Roku能抓住更多“重⼤”广告机会；杰富瑞看好理想汽车对动⼒系统的选择",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "医药股表现强势，“两定”新规将施行，利好龙头连锁药店",
            "features": {
                "keywords": [
                    "医药股",
                    "两定新规",
                    "连锁药店"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药股表现强势，“两定”新规将施行，利好龙头连锁药店",
            "scores": {
                "News_content": "医药股表现强势，“两定”新规将施行，利好龙头连锁药店",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "临床阶段⽣物技术公司天演药业(ADAG.US)赴美上市，药明康德(02359)持股⽐例达10.8%",
            "features": {
                "keywords": [
                    "天演药业",
                    "药明康德",
                    "赴美上市"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "临床阶段⽣物技术公司天演药业(ADAG.US)赴美上市，药明康德(02359)持股⽐例达10.8%",
            "scores": {
                "News_content": "临床阶段⽣物技术公司天演药业(ADAG.US)赴美上市，药明康德(02359)持股⽐例达10.8%",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "花旗：首予药明康德(02359)目标价236港元 评级“买入”",
            "features": {
                "keywords": [
                    "花旗",
                    "药明康德",
                    "买入",
                    "目标价"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "花旗：首予药明康德(02359)目标价236港元 评级“买入”",
            "scores": {
                "News_content": "花旗：首予药明康德(02359)目标价236港元 评级“买入”",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "医药生物⾏业报告：中外新冠疫苗PK 孰优孰劣？",
            "features": {
                "keywords": [
                    "医药生物",
                    "新冠疫苗",
                    "PK"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "医药生物⾏业报告：中外新冠疫苗PK 孰优孰劣？",
            "scores": {
                "News_content": "医药生物⾏业报告：中外新冠疫苗PK 孰优孰劣？",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "解盘：⼩⾦属整体活跃，稀土、动⼒电池、电源设备领涨",
            "features": {
                "keywords": [
                    "小金属",
                    "稀土",
                    "动力电池",
                    "电源设备"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "材料",
                    "新能源"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "解盘：⼩⾦属整体活跃，稀土、动⼒电池、电源设备领涨",
            "scores": {
                "News_content": "解盘：⼩⾦属整体活跃，稀土、动⼒电池、电源设备领涨",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "CXO公司市值暴涨，药明康德接近4000亿；做药or卖水？摆在⽼板⾯前的选择题",
            "features": {
                "keywords": [
                    "CXO",
                    "药明康德",
                    "市值暴涨"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "CXO公司市值暴涨，药明康德接近4000亿；做药or卖水？摆在⽼板⾯前的选择题",
            "scores": {
                "News_content": "CXO公司市值暴涨，药明康德接近4000亿；做药or卖水？摆在⽼板⾯前的选择题",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "药明康德冲击涨停，股价创历史新高",
            "features": {
                "keywords": [
                    "药明康德",
                    "涨停",
                    "股价新高"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "药明康德冲击涨停，股价创历史新高",
            "scores": {
                "News_content": "药明康德冲击涨停，股价创历史新高",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 9,
                "Impact": 10,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "orginal_text": "【异动股】药明康德(02359-HK)涨6.23%",
            "features": {
                "keywords": [
                    "药明康德",
                    "异动股",
                    "涨6.23%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "【异动股】药明康德(02359-HK)涨6.23%",
            "scores": {
                "News_content": "【异动股】药明康德(02359-HK)涨6.23%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "医药股持续⾛强，泰格医药、康龙化成涨逾10%",
            "features": {
                "keywords": [
                    "医药股",
                    "泰格医药",
                    "康龙化成",
                    "涨逾10%"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药股持续⾛强，泰格医药、康龙化成涨逾10%",
            "scores": {
                "News_content": "医药股持续⾛强，泰格医药、康龙化成涨逾10%",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "52只股北向资⾦持有流通盘的⽐例超10%",
            "features": {
                "keywords": [
                    "北向资金",
                    "流通盘",
                    "比例超10%"
                ],
                "sentiment_score": 0.65,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "original_text": "52只股北向资⾦持有流通盘的⽐例超10%",
            "scores": {
                "News_content": "52只股北向资⾦持有流通盘的⽐例超10%",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "策略专题报告：“需求侧管理与消费升级”投资机会挖掘电话会议纪要",
            "features": {
                "keywords": [
                    "需求侧管理",
                    "消费升级",
                    "投资机会"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "策略专题报告：“需求侧管理与消费升级”投资机会挖掘电话会议纪要",
            "scores": {
                "News_content": "策略专题报告：“需求侧管理与消费升级”投资机会挖掘电话会议纪要",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 4,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]